Oncolytic therapy meets efficacy criteria in third-line colorectal cancer cohort of GOBLET study
The results met the efficacy criteria for expanded registration and supported Perolep’s mechanism of action. san diego and Calgary, Alabama, October 23, 2023 /PRNewswire/ — Oncolytic Biotechnology® Inc. (NASDAQ: Oncy(Oncolytics) (TSX: ONC), an oncology-focused clinical-stage immunotherapy company, today announced that microsatellite Discuss metastatic colorectal cancer (CRC) regardless of its instability status. madrid, spain. Oncolytics_Biotech_Grey “The […]